Endogenex
Latest round
- Series C
Last raised
- Mar 2026
Total raised
- $130M
Investors
- 8
About Endogenex
, is the developer of a unique endoscopic method for the treatment of type 2 diabetes. In March 2026, Endogenex, Inc. The company has developed a novel endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. The Endogenex medical gadget is used in the technique for endoscopic duodenal mucosal regeneration (DMR).
Who invested in Endogenex
8 investors across 3 rounds
See all investors in Endogenex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Endogenex
Who invested in Endogenex?
Endogenex has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endogenex raised?
Endogenex has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Endogenex last raise money?
Endogenex's most recent round on record is a Series C, in Mar 2026.
What does Endogenex do?
, is the developer of a unique endoscopic method for the treatment of type 2 diabetes.
Where is Endogenex headquartered?
Endogenex is headquartered in Plymouth, US.
Which VCs invest in companies like Endogenex?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Endogenex's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Endogenex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.